191 related articles for article (PubMed ID: 29261826)
1. Communication About the Probability of Cancer in Indeterminate Pulmonary Nodules.
Maiga AW; Deppen SA; Massion PP; Callaway-Lane C; Pinkerman R; Dittus RS; Lambright ES; Nesbitt JC; Grogan EL
JAMA Surg; 2018 Apr; 153(4):353-357. PubMed ID: 29261826
[TBL] [Abstract][Full Text] [Related]
2. Assessment of Fluorodeoxyglucose F18-Labeled Positron Emission Tomography for Diagnosis of High-Risk Lung Nodules.
Maiga AW; Deppen SA; Mercaldo SF; Blume JD; Montgomery C; Vaszar LT; Williamson C; Isbell JM; Rickman OB; Pinkerman R; Lambright ES; Nesbitt JC; Grogan EL
JAMA Surg; 2018 Apr; 153(4):329-334. PubMed ID: 29117314
[TBL] [Abstract][Full Text] [Related]
3. Development of a Risk Prediction Model to Estimate the Probability of Malignancy in Pulmonary Nodules Being Considered for Biopsy.
Reid M; Choi HK; Han X; Wang X; Mukhopadhyay S; Kou L; Ahmad U; Wang X; Mazzone PJ
Chest; 2019 Aug; 156(2):367-375. PubMed ID: 30940455
[TBL] [Abstract][Full Text] [Related]
4. Indeterminate lung nodules in cancer patients: pretest probability of malignancy and the role of 18F-FDG PET/CT.
Evangelista L; Panunzio A; Polverosi R; Pomerri F; Rubello D
AJR Am J Roentgenol; 2014 Mar; 202(3):507-14. PubMed ID: 24555586
[TBL] [Abstract][Full Text] [Related]
5. Validation of two models to estimate the probability of malignancy in patients with solitary pulmonary nodules.
Schultz EM; Sanders GD; Trotter PR; Patz EF; Silvestri GA; Owens DK; Gould MK
Thorax; 2008 Apr; 63(4):335-41. PubMed ID: 17965070
[TBL] [Abstract][Full Text] [Related]
6. Using radiology reports to encourage evidence-based practice in the evaluation of small, incidentally detected pulmonary nodules. A preliminary study.
Woloshin S; Schwartz LM; Dann E; Black WC
Ann Am Thorac Soc; 2014 Feb; 11(2):211-4. PubMed ID: 24354970
[TBL] [Abstract][Full Text] [Related]
7. Accuracy of clinicians and models for estimating the probability that a pulmonary nodule is malignant.
Balekian AA; Silvestri GA; Simkovich SM; Mestaz PJ; Sanders GD; Daniel J; Porcel J; Gould MK
Ann Am Thorac Soc; 2013 Dec; 10(6):629-35. PubMed ID: 24063427
[TBL] [Abstract][Full Text] [Related]
8. Survival and metastasis in muscle-invasive bladder cancer patients who present with indeterminate pulmonary nodules before treatment.
Al-Daghmin A; Alhamss S; Al-Najjar H; Al-Saidi I; Al-Qasem K; Abukhiran I; Hamad A; Alhusban M
Ann Saudi Med; 2019; 39(1):42-47. PubMed ID: 30712050
[TBL] [Abstract][Full Text] [Related]
9. Physician Assessment of Pretest Probability of Malignancy and Adherence With Guidelines for Pulmonary Nodule Evaluation.
Tanner NT; Porter A; Gould MK; Li XJ; Vachani A; Silvestri GA
Chest; 2017 Aug; 152(2):263-270. PubMed ID: 28115167
[TBL] [Abstract][Full Text] [Related]
10. Differences in VA and Non-VA Pulmonary Nodules: All Evaluations Are not Created Equal.
New ML; Hirsch EA; Feser WJ; Malkoski SP; Garg K; Miller YE; Baron AE
Clin Lung Cancer; 2023 Jul; 24(5):407-414. PubMed ID: 37012147
[TBL] [Abstract][Full Text] [Related]
11. Limited value of logistic regression analysis in solid solitary pulmonary nodules characterization: a single-center experience on 288 consecutive cases.
Perandini S; Soardi GA; Motton M; Dallaserra C; Montemezzi S
J Surg Oncol; 2014 Dec; 110(7):883-7. PubMed ID: 25088475
[TBL] [Abstract][Full Text] [Related]
12. Risk of malignancy in pulmonary nodules: A validation study of four prediction models.
Al-Ameri A; Malhotra P; Thygesen H; Plant PK; Vaidyanathan S; Karthik S; Scarsbrook A; Callister ME
Lung Cancer; 2015 Jul; 89(1):27-30. PubMed ID: 25864782
[TBL] [Abstract][Full Text] [Related]
13. The Thoracic Research Evaluation and Treatment 2.0 Model: A Lung Cancer Prediction Model for Indeterminate Nodules Referred for Specialist Evaluation.
Godfrey CM; Shipe ME; Welty VF; Maiga AW; Aldrich MC; Montgomery C; Crockett J; Vaszar LT; Regis S; Isbell JM; Rickman OB; Pinkerman R; Lambright ES; Nesbitt JC; Maldonado F; Blume JD; Deppen SA; Grogan EL
Chest; 2023 Nov; 164(5):1305-1314. PubMed ID: 37421973
[TBL] [Abstract][Full Text] [Related]
14. A clinical model to estimate the pretest probability of lung cancer in patients with solitary pulmonary nodules.
Gould MK; Ananth L; Barnett PG;
Chest; 2007 Feb; 131(2):383-8. PubMed ID: 17296637
[TBL] [Abstract][Full Text] [Related]
15. The probability of malignancy in solitary pulmonary nodules. Application to small radiologically indeterminate nodules.
Swensen SJ; Silverstein MD; Ilstrup DM; Schleck CD; Edell ES
Arch Intern Med; 1997 Apr; 157(8):849-55. PubMed ID: 9129544
[TBL] [Abstract][Full Text] [Related]
16. Relationship between a history of antecedent cancer and the probability of malignancy for a solitary pulmonary nodule.
Mery CM; Pappas AN; Bueno R; Mentzer SJ; Lukanich JM; Sugarbaker DJ; Jaklitsch MT
Chest; 2004 Jun; 125(6):2175-81. PubMed ID: 15189939
[TBL] [Abstract][Full Text] [Related]
17. A prediction model for lung metastases in patients with indeterminate pulmonary nodules in newly diagnosed colorectal cancer.
Nuijens BW; Lindeboom R; van den Broek JJ; Geenen RWF; Schreurs WH
Eur J Surg Oncol; 2024 Jun; 50(6):108305. PubMed ID: 38552417
[TBL] [Abstract][Full Text] [Related]
18. Distress and patient-centered communication among veterans with incidental (not screen-detected) pulmonary nodules. A cohort study.
Slatore CG; Golden SE; Ganzini L; Wiener RS; Au DH
Ann Am Thorac Soc; 2015 Feb; 12(2):184-92. PubMed ID: 25521482
[TBL] [Abstract][Full Text] [Related]
19. [Risk factor analysis of the patients with solitary pulmonary nodules and establishment of a prediction model for the probability of malignancy].
Wang X; Xu YH; Du ZY; Qian YJ; Xu ZH; Chen R; Shi MH
Zhonghua Zhong Liu Za Zhi; 2018 Feb; 40(2):115-120. PubMed ID: 29502371
[No Abstract] [Full Text] [Related]
20. Resource use and guideline concordance in evaluation of pulmonary nodules for cancer: too much and too little care.
Wiener RS; Gould MK; Slatore CG; Fincke BG; Schwartz LM; Woloshin S
JAMA Intern Med; 2014 Jun; 174(6):871-80. PubMed ID: 24710850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
